The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib

BackgroundDifferent peripheral blood markers have been reported to be involved in different stages of breast cancer development and metastasis. However, the association between NLR, LDH and prognosis of pyrotinib in HER2-positive metastatic breast cancer (mBC) remains unknown.MethodsWe collected the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wenqi Zhou, Jing Wu, Peng Zhang, Jing Xiong, Yi Yang, Xiaohua Zeng, Wei Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-05-01
coleção:	Frontiers in Oncology
Assuntos:	HER2 positive breast cancer LDH NLR prognosis pyrotinib
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1812069/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!